ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Association between Everolimus Trough Levels, Onset of Related Adverse Events, and Treatment Discontinuation after Liver Transplantation: 24-Month Results from the H2304 Study

    J. Fung,1 F. Saliba,1 H. Schlitt,1 G. Junge,2 K. McCague,3 D. Patel,3 M. Charlton.1

    1H2304 Study Group, Chicago; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis Pharmaceuticals Corporation, East Hanover.

    Purpose: Evaluation of mammalian target of rapamycin inhibitor (mTORi)-related adverse events (AEs) and drug trough levels (C0) at onset may aid their management in liver…
  • 2018 American Transplant Congress

    Post-Hoc Analysis of Everolimus Trough Levels around the Onset of Related Adverse Events and Treatment Discontinuation in De Novo Kidney Transplant Recipients from the US92 Study

    F. Shihab,1 Y. Qazi,1 V. Peddi,1 D. Shaffer,1 K. McCague,2 D. Patel,2 S. Mulgaonkar.1

    1US92 Study Group, Salt Lake City; 2Novartis Pharmaceutical Corporation, East Hanover.

    Purpose: Around 30%-50% of kidney transplant recipients (KTR) on sirolimus discontinue treatment due to drug-related adverse events (AE) and ~23% on everolimus (EVR) discontinue treatment…
  • 2018 American Transplant Congress

    Metabolic Regulation of Neuropeptides Induces Weight Loss and is Linked to Prolongation of Allograft Survival

    M. Quante,1,2 T. Heinbokel,1 K. Minami,1 Y. Nian,1 A. Elkhal,1 S. Tullius.1

    1Transplant Surgery Research Lab, Brigham and Women's Hospital, Boston, MA; 2Department of General, Visceral and Transplant Surgery, Tuebingen Unversity Hospital, Tuebingen, Germany.

    Obesity has become a common comorbidity among transplant recipients that is linked to inferior transplant outcome through far-reaching effects on metabolism, inflammation and immunity. Increasingly,…
  • 2018 American Transplant Congress

    Application of RNA-Seq Derived Diagnostic Algorithms of T-Cell Mediated Kidney Rejection (TCMR) to DNA Microarray-Based Gene Expression Datasets

    Z. Wang,1 L. Pan,2 Z. Lyu,2 P. Liu,3 G. Tseng,3 P. Randhawa.1

    1Department of Pathology, The Thomas E Starzl Transplantation Institute, University of Pittsburgh, School of Medicine, Pittsburgh, PA; 2Department of Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China; 3Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.

    Recent years have seen the development of DNA microarray based tools for the diagnosis of TCMR using fresh frozen tissue. This study has accomplished the…
  • 2018 American Transplant Congress

    Self-Reported Post-Surgical Pain Following Living Kidney Donation

    A. Fleishman,1 J. Schold,2 P. Morrissey,3 J. Whiting,4 J. Vella,4 L. Kayler,5 D. Katz,6 J. Jones,6 B. Kaplan,7 M. Pavlakis,1 D. Mandelbrot,8 J. Rodrigue.1

    1Beth Israel Deaconess Medical Center, Boston; 2Cleveland Clinic, Boston; 3Rhode Island Hospital, Providence; 4Maine Medical Center, Portland; 5University of Buffalo, Buffalo; 6University of Iowa, Iowa City; 7May Clinic, Scottsdale; 8University of Wisconsin, Madison.

    The Kidney Donor Outcomes Cohort (KDOC) is an NIH-funded observational cohort study evaluating outcomes in living kidney donors (LKDs) at 6 US centers. LKDs completed…
  • 2018 American Transplant Congress

    Chronic Changes on Time Zero Living Donor Allograft Biopsy Portraits Worse Donor Renal Function

    A. Nishio-Lucar,1 J. Murphy,2 A. Sites,3 H. Cathro,2 A. Doyle,1 K. Warburton,1 A. Agarwal.4

    1Medicine, University of Virginia, Charlottesville, VA; 2Pathology, University of Virginia, Charlottesville, VA; 3Transplant Services, University of Virginia, Charlottesville, VA; 4Surgery, University of Virginia, Charlottesville, VA.

    The prognostic ability of zero hour biopsy (ZHB) in renal allografts has not been fully elucidated. ZHB utility predicting living kidney donor (LKD) renal recovery…
  • 2018 American Transplant Congress

    The Impact of Duration on Dialysis on the Pre-Transplant Allosensitization According to Panel Reactive Antibody Levels

    Y. Jung,1 D. Kim,1 J. Lee,1 S. Song,2 J. Lee,3 B. Kim,4 J. Lee,1 S. Kim,1 M. Kim,1 S. Kim,1 Y. Kim,1 K. Huh.1

    1Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea; 2Department of Surgery, College of Medicine, Ewha Women's University, Seoul, Republic of Korea; 3Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea; 4Departments of Nephrology, Yonsei University College of Medicine, Seoul, Republic of Korea.

    Purpose : Presensitization to human leukocyte antigen(HLA) is one of the most important barriers to overcome in the field of renal transplantation. Due to the…
  • 2018 American Transplant Congress

    Spigelius' Line Incision as a Successful Route to Extract the Kidney during Retroperitoneal Laparoscopic Live-Donor Nephrectomy

    J. Qiu, G. Chen, Z. Wu, C. Wang, L. Chen.

    Organ Transplantation, The First Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong, China.

    To introduce the advantages, incision designing methods and surgical procedures of spigelius' line incision in retroperitoneal laparoscopic living donor nephrectomy.Methods: The clinical data of 114…
  • 2018 American Transplant Congress

    Effects of Medication Education Pilot Program in Living versus Deceased Donor Kidney Transplant Recipients.

    N. Sulejmani, H. Albanna, B. Summers, A. Jantz, R. Prashar, A. Patel.

    Henry Ford Transplant Institute, Detroit, MI.

    Purpose: Medication adherence is crucial for transplant recipients as non-adherence can result in increased risk of rejection and graft loss. Early education prior to transplant…
  • 2018 American Transplant Congress

    South Asian and Muslim Canadian Patients Are Less Likely to Receive Living Donor Kidney Transplant Offers Compared to Caucasian, Non-Muslim Patients

    A. Ali,1 A. Ayub,1 C. Richardson,1 N. Edwards,1 T. Ahmed,1 M. Novak,2,3 I. Mucsi.1

    1Multi-Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada; 2Centre for Mental Health, University Health Network, Toronto, ON, Canada; 3Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

    Background:No studies have assessed whether Muslim Canadians face barriers to accessing LDKT. We explored how frequently Muslim or South Asian patients with and stage kidney…
  • « Previous Page
  • 1
  • …
  • 764
  • 765
  • 766
  • 767
  • 768
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences